What is Abbott Laboratories' stock symbol?
Abbott Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABT."
How often does Abbott Laboratories pay dividends? What is the dividend yield for Abbott Laboratories?
Abbott Laboratories declared a quarterly dividend on Friday, February 17th. Investors of record on Friday, April 14th will be paid a dividend of $0.265 per share on Monday, May 15th. This represents a $1.06 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date is Tuesday, April 11th.
Where is Abbott Laboratories' stock going? Where will Abbott Laboratories' stock price be in 2017?
18 brokerages have issued twelve-month price objectives for Abbott Laboratories' stock. Their forecasts range from $40.00 to $55.00. On average, they expect Abbott Laboratories' share price to reach $48.17 in the next year.
When will Abbott Laboratories announce their earnings?
Abbott Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, April, 18th 2017.
What are analysts saying about Abbott Laboratories stock?
Here are some recent quotes from research analysts about Abbott Laboratories stock:
According to Zacks Investment Research, "Abbott has been reshaping its portfolio through strategic acquisitions/divestitures for long-term growth. The St. Jude Medical buyout will complement its cardiovascular devices business. On the other hand, in order to focus on key areas, cardiovascular devices and diagnostics, Abbott inked a deal to divest its vision care business, Medical Optics, to J&J. Abbott’s initiative to realign the EPD segment was a step in the right direction given the challenging market conditions faced by the division. Shares of Abbott has outperformed the Zacks classified Large cap pharmaceuticals industry in the last one month. The company recently filed a complaint to terminate its proposed acquisition of Alere, based on a substantial deterioration in the latter’s value following the merger agreement. Also, weakness in the nutrition business in China and sluggish growth in the Venezuelan market is concerning." (1/11/2017)
Credit Suisse Group analysts commented, "We expect a fairly high level of physician interest in Absorb in straightforward lesions. Our Jan. survey of US cardiologists implied 11% Absorb unit share in year 1 post-launch, though, assuming approval, we expect Absorb to face reimbursement/coverage challenges if a meaningful price premium is established (until/unless longer- term data shows an outcomes benefit). We currently forecast 5% US Absorb unit share in 2017 of which ½ comes from Xience & ½ from BSX/MDT. Share price performance 36 41 46 51 Mar-15 Jun-15 Sep-15 Dec-15 Daily Mar 16, 2015 – Mar 11, 2016, 3/16/15 = US$47.83 Price Indexed S&P 500 INDEX On 03/11/16 the S&P 500 INDEX closed at 2022.19 Quarterly EPS Q1 Q2 Q3 Q4 2015A 0.47 0.52 0.55 0.62 2016E 0.39 0.54 0.58 0.66 2017E 0.44 0.61 0.65 0.74 Financial and valuation metrics Year 12/15A 12/16E 12/17E 12/18E EPS (CS adj.) (US$) 2.16 2.17 2.43 2.71 Prev. EPS (US$) — — — — P/E (x) 18.7 18.6 16.6 14.9 P/E rel." (3/15/2016)
Who owns Abbott Laboratories stock?
Abbott Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (4.60%), FMR LLC (0.94%), Franklin Resources Inc. (0.60%), Institutional Capital LLC (0.51%), Dimensional Fund Advisors LP (0.46%) and Westwood Holdings Group Inc. (0.30%). Company insiders that own Abbott Laboratories stock include Brian B Yoor, Brian J Blaser, Daniel Gesua Sive Salvadori, Deepak S Nath, Heather L Mason, Hubert L Allen, J Scott White, Jaime Contreras, Jared Watkin, Michael J Warmuth, Miles D White, Robert B Ford, Robert E Funck, Roger Bird, Sally E Blount and Stephen R Fussell.
Who sold Abbott Laboratories stock? Who is selling Abbott Laboratories stock?
Abbott Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Thrivent Financial for Lutherans, FMR LLC, AQR Capital Management LLC, Institutional Capital LLC, Franklin Resources Inc., Aberdeen Asset Management PLC UK and Orbimed Advisors LLC. Company insiders that have sold Abbott Laboratories stock in the last year include Brian B Yoor, Daniel Gesua Sive Salvadori, Deepak S Nath, Heather L Mason, Hubert L Allen, Jaime Contreras, Jared Watkin, Michael J Warmuth, Robert E Funck, Roger Bird and Stephen R Fussell.
Who bought Abbott Laboratories stock? Who is buying Abbott Laboratories stock?
Abbott Laboratories' stock was purchased by a variety of institutional investors in the last quarter, including Westwood Holdings Group Inc., Dimensional Fund Advisors LP, Asset Management One Co. Ltd., Renaissance Technologies LLC, State Street Corp, Russell Investments Group Ltd., Loomis Sayles & Co. L P and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main. Company insiders that have bought Abbott Laboratories stock in the last two years include Brian J Blaser, Miles D White, Robert B Ford and Sally E Blount.
How do I buy Abbott Laboratories stock?
Shares of Abbott Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Abbott Laboratories stock cost?
One share of Abbott Laboratories stock can currently be purchased for approximately $45.08.